Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,724 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein.
Kim C, Ryu DK, Lee J, Kim YI, Seo JM, Kim YG, Jeong JH, Kim M, Kim JI, Kim P, Bae JS, Shim EY, Lee MS, Kim MS, Noh H, Park GS, Park JS, Son D, An Y, Lee JN, Kwon KS, Lee JY, Lee H, Yang JS, Kim KC, Kim SS, Woo HM, Kim JW, Park MS, Yu KM, Kim SM, Kim EH, Park SJ, Jeong ST, Yu CH, Song Y, Gu SH, Oh H, Koo BS, Hong JJ, Ryu CM, Park WB, Oh MD, Choi YK, Lee SY. Kim C, et al. Among authors: kim ji, kim yi, kim ss, kim eh, kim ms, kim m, kim kc, kim p, kim sm, kim jw, kim yg. Nat Commun. 2021 Jan 12;12(1):288. doi: 10.1038/s41467-020-20602-5. Nat Commun. 2021. PMID: 33436577 Free PMC article.
The Architecture of SARS-CoV-2 Transcriptome.
Kim D, Lee JY, Yang JS, Kim JW, Kim VN, Chang H. Kim D, et al. Among authors: kim vn, kim jw. Cell. 2020 May 14;181(4):914-921.e10. doi: 10.1016/j.cell.2020.04.011. Epub 2020 Apr 23. Cell. 2020. PMID: 32330414 Free PMC article.
Persistence of the neutralizing antibody response after SARS-CoV-2 infection.
Shim SM, Kim JW, Jung S, Jung Y, Woo HM, Yang JS, Kim KC, Lee JY. Shim SM, et al. Among authors: kim kc, kim jw. Clin Microbiol Infect. 2022 Apr;28(4):614.e1-614.e4. doi: 10.1016/j.cmi.2021.12.012. Epub 2021 Dec 23. Clin Microbiol Infect. 2022. PMID: 34954127 Free PMC article.
Duration of Humoral Immunity and Cross-Neutralizing Activity Against the Alpha, Beta, and Delta Variants After Wild-Type Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Prospective Cohort Study.
Noh JY, Yang JS, Hwang SY, Hyun H, Seong H, Gu Yoon J, Yoon SY, Cheong HJ, Kim WJ, Park WJ, Kim JW, Lee JY, Song JY. Noh JY, et al. Among authors: kim wj, kim jw. J Infect Dis. 2022 Sep 21;226(6):975-978. doi: 10.1093/infdis/jiac050. J Infect Dis. 2022. PMID: 35172333 Free PMC article.
Preclinical assessment and randomized Phase I study of CT-P63, a broadly neutralizing antibody targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Seo JM, Kang B, Song R, Noh H, Kim C, Kim JI, Kim M, Ryu DK, Lee MH, Yang JS, Kim KC, Lee JY, Lee H, Woo HM, Kim JW, Choi JA, Song M, Tomaszewska-Kiecana M, Wołowik A, Kulesza A, Kim S, Ahn K, Jung N, Lee SY. Seo JM, et al. Among authors: kim ji, kim c, kim s, kim m, kim kc, kim jw. Emerg Microbes Infect. 2022 Dec;11(1):2315-2325. doi: 10.1080/22221751.2022.2117094. Emerg Microbes Infect. 2022. PMID: 36006772 Free PMC article. Clinical Trial.
Can nirmatrelvir/ritonavir treatment shorten the duration of COVID-19 isolation?
Kim H, Yang JS, Ko JH, Lee M, Lee JY, Park S, Kim JW, Shin Y, Lee JM, Na YJ, Park BK, Kim H, Lee YH, Yang J, Huh K, Cho SY, Kang CI, Chung DR, Peck KR. Kim H, et al. Among authors: kim jw. Front Med (Lausanne). 2022 Oct 12;9:988559. doi: 10.3389/fmed.2022.988559. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36314031 Free PMC article.
Relative infectivity of the SARS-CoV-2 Omicron variant in human alveolar cells.
Kim T, Min KI, Yang JS, Kim JW, Cho J, Kim YH, Lee JS, Kim YT, Kim KC, Kim JY, Na KJ, Lee JY, Ju YS. Kim T, et al. Among authors: kim yh, kim jy, kim kc, kim yt, kim jw. iScience. 2022 Dec 22;25(12):105571. doi: 10.1016/j.isci.2022.105571. Epub 2022 Nov 13. iScience. 2022. PMID: 36406862 Free PMC article.
8,724 results